Athersys May Get Up To $111M from Pfizer In Stem-Cell Deal
Pfizer signed a deal worth $111 million with Athersys involving development of the MultiStem product in the area of inflammatory bowel disease.
Pfizer signed a deal worth $111 million with Athersys involving development of the MultiStem product in the area of inflammatory bowel disease.
Because of their central role, the proteins could offer a safe and novel therapeutic target in many cancers. The proteins that arrest the multiplication of the cell may be considered as tumor suppressor proteins.
After 17 months Lava Man is scheduled to make a come-back this Saturday at Hollywood Park in the Native Diver Handicap. The horse was treated with his own fat derived stem cells by Dr. Doug Herthel.
University of Florida McKnight Brain Institute received a $2.4 million National Institutes of Health grant to study regenerative process of the Mexican axolotl salamander with the aim of applying biological lessons learned to spinal cord injury.
The New England Journal of Medicine reported a clinical trial at the Clinical Center of the National Institutes of Health in Bethesda, that described successful treatment of 9 out of 10 adults suffering from Sickle cell anemia.
Dr. Jialiang Wang of Duke University reported that Notch signaling in tumor tissue is related to the failure of radiation treatments.
Toll Free:
1-800-980-STEM (7836)
Outside or Inside US Call:
1-954-358-3382
Toll Free Fax (US Only):
1-866-755-3951
From Outside US Fax:
1-775-887-1194
Copyright 2025, Stem Cell Insitute Panama. All rights reserved.